Fraunhofer Institute for Cell Therapy and Immunology IZI. Biochemistry and Molecular Drug Therapy Development Group ^Hubs

The Department of Drug Design and Target Validation develops new molecular therapies for neurodegenerative and inflammatory diseases. The department’s expertise is based on an in depth pharma-like understanding of scientific work and a long-lasting experience in the field of drug development.